Skip to main content
Josanna Rodriguez-Lopez, MD, Pulmonology, Boston, MA

JosannaMariRodriguez-LopezMD

Pulmonology Boston, MA

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

Director Pulmonary Hypertension Program, Massachusetts General Hospital

Dr. Rodriguez-Lopez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodriguez-Lopez's full profile

Already have an account?

  • Office

    55 Fruit st
    Boston, MA 02114

Summary

  • Dr. Josanna Rodriguez-Lopez is a pulmonologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from NYU School of Medicine and has been in practice 13 years. She specializes in critical care medicine and pulmonary vascular medicine and is experienced in critical care medicine, pulmonary vascular disease, and Venous thromboembolic disease.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
  • New York University School of Medicine
    New York University School of MedicineClass of 2004

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2021 - 2026
  • MA State Medical License
    MA State Medical License 2012 - 2025
  • NY State Medical License
    NY State Medical License 2006 - 2013
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Clinical Trial Successfully Repurposes Cancer Drug for Hereditary Bleeding Disorder
    Clinical Trial Successfully Repurposes Cancer Drug for Hereditary Bleeding DisorderSeptember 18th, 2024